Literature DB >> 15808406

Transcriptional signatures of environmentally relevant exposures in normal human mammary epithelial cells: benzo[a]pyrene.

Channa Keshava1, Diana Whipkey, Ainsley Weston.   

Abstract

Changes in gene expression in a panel of primary normal human mammary epithelial cell strains, developed from healthy breast tissue obtained at reduction mammoplasty from different donors, in response to benzo[a]pyrene exposure have been investigated. It was expected that both gene expression changes common to cell strains derived from different donors as well as inter-individual variation would be observed. Therefore, the strategy that has been adopted is to identify potentially important changes, or useful changes from a biomonitoring perspective, using gene-array technology and a small number of donors; then investigate selected transcription responses using a large number of tissue donors and a cheaper method of transcript detection (real-time polymerase chain reaction). Here we report results from four primary normal human mammary epithelial cell strains that were treated with benzo[a]pyrene in vitro for either 6 or 24 h. Transcription was monitored using high-density oligonucleotide arrays (Affymetrix HuGeneFL). Total RNA was used for the preparation of labeled targets that were hybridized to microarrays containing probes representing more than 6800 human genes and expressed sequence tags. Gene expression data were analyzed using the GeneChip software (MAS 5.0). Altered gene expression patterns were observed in response to benzo[a]pyrene in human mammary epithelial cell strains from different donors. Specifically, the dioxin inducible cytochrome P450 CYP1B1 was consistently induced in response to 6 and 24 h exposure to benzo[a]pyrene in cell strains from all four donors. Two other genes that were relatively consistently induced were IL1beta and MMP1. Less consistent changes in other metabolism genes (CYP1A1, CYP11B2, and NQO1) and certain cell cycle control genes GOS2 and AF1Q were also induced, while EGR1 was suppressed. Although no change in p53 transcription was observed, an accumulation of p53 protein was detected using antibodies. A similar accumulation of Waf1 (p21) was also observed using immunohistochemistry, this was expected since p53 is p21's transcription factor. Significant inter-individual variations in both the levels and patterns of gene expression were observed, in response to benzo[a]pyrene exposure. These studies provide a complementary approach to molecular epidemiology for the investigation of differential susceptibility to chemical carcinogens, and specifically polycyclic aromatic hydrocarbons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808406     DOI: 10.1016/j.canlet.2004.08.037

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

1.  Centrosomal amplification and aneuploidy induced by the antiretroviral drug AZT in hamster and human cells.

Authors:  Jennifer P Borojerdi; Jessica Ming; Catherine Cooch; Yvona Ward; Cristina Semino-Mora; Mia Yu; Hannan M Braun; Barbara J Taylor; Miriam C Poirier; Ofelia A Olivero
Journal:  Mutat Res       Date:  2009-03-24       Impact factor: 2.433

2.  Centrosome amplification induced by the antiretroviral nucleoside reverse transcriptase inhibitors lamivudine, stavudine, and didanosine.

Authors:  Mia Yu; Yvona Ward; Miriam C Poirier; Ofelia A Olivero
Journal:  Environ Mol Mutagen       Date:  2009-10       Impact factor: 3.216

Review 3.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

4.  Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2.

Authors:  Sarah L Hockley; Volker M Arlt; Daniel Brewer; Ian Giddings; David H Phillips
Journal:  BMC Genomics       Date:  2006-10-16       Impact factor: 3.969

5.  Diallyl trisulfide as an inhibitor of benzo(a)pyrene-induced precancerous carcinogenesis in MCF-10A cells.

Authors:  Yasmeen M Nkrumah-Elie; Jayne S Reuben; Alicia Hudson; Equar Taka; Ramesh Badisa; Tiffany Ardley; Bridg'ette Israel; Sakeenah Y Sadrud-Din; Ebenezer Oriaku; Selina F Darling-Reed
Journal:  Food Chem Toxicol       Date:  2012-04-16       Impact factor: 6.023

6.  CYP1A1 and CYP1B1 gene expression and DNA adduct formation in normal human mammary epithelial cells exposed to benzo[a]pyrene in the absence or presence of chlorophyllin.

Authors:  Kaarthik John; Rao L Divi; Channa Keshava; Christine C Orozco; Marie E Schockley; Diana L Richardson; Miriam C Poirier; Joginder Nath; Ainsley Weston
Journal:  Cancer Lett       Date:  2010-02-16       Impact factor: 8.679

7.  Human inter-individual variability in metabolism and genotoxic response to zidovudine.

Authors:  Ofelia A Olivero; Jessica M Ming; Shreyasi Das; Irma L Vazquez; Diana L Richardson; Ainsley Weston; Miriam C Poirier
Journal:  Toxicol Appl Pharmacol       Date:  2007-12-14       Impact factor: 4.219

8.  The attenuation of early benzo(a)pyrene-induced carcinogenic insults by diallyl disulfide (DADS) in MCF-10A cells.

Authors:  Yasmeen M Nkrumah-Elie; Jayne S Reuben; Alicia M Hudson; Equar Taka; Ramesh Badisa; Tiffany Ardley; Bridg'ette Israel; Sakeenah Y Sadrud-Din; Ebenezer T Oriaku; Selina F Darling-Reed
Journal:  Nutr Cancer       Date:  2012-09-24       Impact factor: 2.900

9.  Activation of dioxin response element (DRE)-associated genes by benzo(a)pyrene 3,6-quinone and benzo(a)pyrene 1,6-quinone in MCF-10A human mammary epithelial cells.

Authors:  Scott W Burchiel; Todd A Thompson; Fredine T Lauer; Tudor I Oprea
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-13       Impact factor: 4.219

10.  Influence of cell cycle on responses of MCF-7 cells to benzo[a]pyrene.

Authors:  Hamza Hamouchene; Volker M Arlt; Ian Giddings; David H Phillips
Journal:  BMC Genomics       Date:  2011-06-29       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.